Article info
PDFPostScript
Letter
Molecular characterisation and cetuximab-based treatment in a patient with refractory small bowel adenocarcinoma
- Correspondence to Dr Sara De Dosso, Oncology Institute of Southern Switzerland, 6500 Bellinzona, Switzerland; Sara.Dedosso{at}eoc.ch
Citation
Molecular characterisation and cetuximab-based treatment in a patient with refractory small bowel adenocarcinoma
Publication history
- First published August 23, 2010.
Online issue publication
April 18, 2016
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.